Significant number of births from women in the high risk category along with rising awareness will drive the growth of NIPT industry, says RNCOS.
Noida, UP -- (SBWIRE) -- 01/07/2015 -- On average about 15% of the total births in Middle Eastern countries is contributed by women belonging to the high risk category for chromosomal abnormalities. With rising awareness among people and changing attitudes towards prenatal testing, the women in the high risk category will have the potential to drive the growth of the market in the coming years.
According to our report, "Middle East NIPT Market Outlook", the Middle East has emerged as a lucrative market for NIPT, whose total potential for the year 2013 was US$ 1.09 Billion. The report helps shed a light on the present scenario in the Middle Eastern countries and elaborates the role of evolving perception in improving the scope of NIPT in the region.
We have identified key countries within the Middle East which hold the maximum potential for NIPT. These countries include UAE, Saudi Arabia, Israel, Kuwait and Qatar. In the report, we discuss the various drivers, challenges and regulatory developments that have been helping shape the current market. We talk about the contribution of advanced maternal age and consanguinity to the high incidence of Down's syndrome and its impact on the potential market. For every country, a detailed analysis has been presented in terms of total number of births, the contribution of the high risk births in the total number of births and the total potential market.
At the end, we have presented recent developments around genetic screening and pregnancy termination that have taken place in the Middle East and their possible impact on the market. The report comes to a conclusion with a future outlook section which emphasizes that with regulatory developments like Israel's announcement of making abortions free, the attitudes towards prenatal screening are changing and will in turn benefit the NIPT industry.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM724.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.